News
I finally felt like a survivor the day I heard my 18-month scans were clear, shifting from fear to faith and realizing I was ...
Dr. Joshua Sabari and Jackie Herigodt discuss the Imerman Angels organization and the importance of recognizing the person ...
Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...
For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.
The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results